Marinus Pharmaceuticals Inc (MRNS)
1.45
-0.02
(-1.69%)
USD |
NASDAQ |
Apr 23, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 04:22
Marinus Pharmaceuticals Price to Book Value: 4.751 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 4.751 |
| April 22, 2024 | 4.833 |
| April 19, 2024 | 4.522 |
| April 18, 2024 | 4.620 |
| April 17, 2024 | 4.718 |
| April 16, 2024 | 3.932 |
| April 15, 2024 | 4.260 |
| April 12, 2024 | 24.64 |
| April 11, 2024 | 25.95 |
| April 10, 2024 | 26.51 |
| April 09, 2024 | 27.46 |
| April 08, 2024 | 26.87 |
| April 05, 2024 | 25.56 |
| April 04, 2024 | 28.44 |
| April 03, 2024 | 28.51 |
| April 02, 2024 | 29.06 |
| April 01, 2024 | 29.39 |
| March 28, 2024 | 29.46 |
| March 27, 2024 | 28.84 |
| March 26, 2024 | 28.65 |
| March 25, 2024 | 29.11 |
| March 22, 2024 | 28.71 |
| March 21, 2024 | 29.37 |
| March 20, 2024 | 29.46 |
| March 19, 2024 | 30.31 |
| Date | Value |
|---|---|
| March 18, 2024 | 29.40 |
| March 15, 2024 | 30.61 |
| March 14, 2024 | 29.17 |
| March 13, 2024 | 30.77 |
| March 12, 2024 | 30.25 |
| March 11, 2024 | 27.64 |
| March 08, 2024 | 28.84 |
| March 07, 2024 | 28.52 |
| March 06, 2024 | 29.43 |
| March 05, 2024 | 30.12 |
| March 04, 2024 | 31.09 |
| March 01, 2024 | 32.33 |
| February 29, 2024 | 30.96 |
| February 28, 2024 | 32.11 |
| February 27, 2024 | 32.57 |
| February 26, 2024 | 32.54 |
| February 23, 2024 | 31.82 |
| February 22, 2024 | 31.33 |
| February 21, 2024 | 31.75 |
| February 20, 2024 | 31.07 |
| February 16, 2024 | 32.44 |
| February 15, 2024 | 32.57 |
| February 14, 2024 | 32.60 |
| February 13, 2024 | 32.24 |
| February 12, 2024 | 33.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.962
Minimum
Jul 24 2019
367.59
Maximum
Aug 24 2022
21.98
Average
5.644
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 1.991 |
| DiaMedica Therapeutics Inc | 1.799 |
| Ligand Pharmaceuticals Inc | 1.765 |
| Soligenix Inc | 1.669 |
| Macrogenics Inc | 6.631 |
Price to Book Value Related Metrics
| PS Ratio | 2.515 |
| PEG Ratio | -0.0011 |
| Price | 1.45 |
| Earnings Yield | -181.4% |
| Market Cap | 79.65M |
| PEGY Ratio | -0.0011 |